PDCD1 and Sjogren syndrome: demonstrated that the removal of PD-1 restriction is effective in alleviating autoimmune disease symptoms in murine models with arthritis, multiple sclerosis and Sjögren’s syndrome by targeting the cis-PD-L1–CD80 duplex (34).